Novel target genes and a valid biomarker panel identified for cholangiocarcinoma

Abstract

Cholangiocarcinoma is notoriously difficult to diagnose, and the mortality rate is high due to late clinical presentation. CpG island promoter methylation is frequently seen in cancer development. In the present study, we aimed at identifying novel epigenetic biomarkers with the potential to improve the diagnostic accuracy of cholangiocarcinoma. Microarray… (More)
DOI: 10.4161/epi.22191

Topics

4 Figures and Tables

Cite this paper

@inproceedings{Andresen2012NovelTG, title={Novel target genes and a valid biomarker panel identified for cholangiocarcinoma}, author={Kim Andresen and Kirsten Muri Boberg and Hege Marie Vedeld and Hilde Honne and Merete Hektoen and Chrisopher A. Wadsworth and Ole Petter Fraas Clausen and Tom H. Karlsen and Aksel Espen Foss and \Oystein Mathisen and Erik Schrumpf and Ragnhild A. Lothe and Guro E Lind}, booktitle={Epigenetics}, year={2012} }